Page last updated: 2024-12-06

4-phenylbenzoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-phenylbenzoic acid: RN given refers to 4-carboxylic cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID66724
CHEMBL ID107057
SCHEMBL ID38562
MeSH IDM0107845

Synonyms (60)

Synonym
HMS1577C04
nsc23040
nsc-23040
4-carboxybiphenyl
biphenyl-4-carboxylic acid
4-phenylbenzoic acid
para phenyl benzoic acid
[1,1'-biphenyl]-4-carboxylic acid
diphenyl-4-carboxylic acid
p-phenylbenzoic acid
4-biphenylcarboxylic acid
4-carboxy-1,1'-biphenyl)
4-diphenylcarboxylic acid
92-92-2
(1,1'-biphenyl)-4-carboxylic acid
nsc 23040
einecs 202-203-1
brn 0973519
4-carboxy-(1,1'-biphenyl)
CBDIVE_013344
biphenyl-4-carboxylic acid, 95%
STK290994
B-2800
AC-2930
CHEMBL107057 ,
P0961
bdbm50060971
AKOS000119566
A844391
unii-36j7vpo67k
4-09-00-02479 (beilstein handbook reference)
36j7vpo67k ,
BBL011579
FT-0602180
AS-2102
AR3938
AE-641/00160032
AB01141504-04
[1,1'-biphenyl]-4carboxylic acid
4-phenyl benzoic acid
4-biphenyl carboxylic acid
4-biphenylylcarboxylic acid
SCHEMBL38562
DTXSID1059074
1,1'-biphenyl-4-carboxylic acid
4-biphenylcarboxylicacid
4-carboxy-1,1'-biphenyl
benzoic acid, p-phenyl-
biphenylcarboxylic acid-(4)
p-biphenylcarboxylic acid
mfcd00002553
F2191-0106
CS-D1119
SY003371
Q27894061
EN300-20144
AMY40948
NCGC00334267-01
z7z ,
Z104477046

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"A pharmacokinetic model of the maternal-fetal amniotic fluid system was designed to permit calculation of clearances from the steady-state concentrations of p-phenylbenzoic acid (PPBA) during infusion of PPBA into the maternal vein and the amniotic fluid of pregnant rats on the 16th to the 21st day of gestation."( Pharmacokinetics of clearance in the maternal-fetal amniotic fluid system of the rat.
Nanbo, T, 1988
)
0.27
" PPBA level in fetal plasma was different from that in maternal central and peripheral compartment based on pharmacokinetic analysis."( Pharmacokinetics in maternal-fetal unit after intravenous administration of p-phenyl benzoic acid to rat.
Nanbo, T, 1982
)
0.26
"The change in the pharmacokinetic character of p-phenyl benzoic acid (PPBA) in developing fetus of rat was investigated by a constant infusion of 14C-PPBA."( Change in pharmacokinetic character of a p-phenyl benzoic acid in developing fetus of rat.
Nanbo, T, 1982
)
0.26
"Disposition of p-phenylbenzoic acid (PPBA) in the pregnant Wistar rat (for both mother and fetuses) was predicted by using a physiologically based pharmacokinetic model."( Physiologically based pharmacokinetic prediction of p-phenylbenzoic acid disposition in the pregnant rat.
Kawahara, M; Nanbo, T; Tsuji, A, 1998
)
0.3

Bioavailability

ExcerptReferenceRelevance
" The problem of bioavailability of aromatic compounds in cell culture assays and the relation to lipophilicity was addressed."( Biologic testing of leachable aromatic compounds from denture base materials.
Gjerdet, NR; Lygre, H; Moe, G; Solheim, E, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)139.64500.03403.987110.0000AID1628074; AID1628075
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Vascular endothelial growth factor AHomo sapiens (human)Kd5,000.00000.00220.16490.4760AID217168
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (115)

Processvia Protein(s)Taxonomy
cellular response to starvationAlbuminHomo sapiens (human)
negative regulation of mitochondrial depolarizationAlbuminHomo sapiens (human)
cellular response to calcium ion starvationAlbuminHomo sapiens (human)
cellular oxidant detoxificationAlbuminHomo sapiens (human)
transportAlbuminHomo sapiens (human)
positive regulation of receptor signaling pathway via STATVascular endothelial growth factor AHomo sapiens (human)
negative regulation of miRNA transcriptionVascular endothelial growth factor AHomo sapiens (human)
positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesisVascular endothelial growth factor AHomo sapiens (human)
branching involved in blood vessel morphogenesisVascular endothelial growth factor AHomo sapiens (human)
positive regulation of endothelial cell proliferationVascular endothelial growth factor AHomo sapiens (human)
regulation of nitric oxide mediated signal transductionVascular endothelial growth factor AHomo sapiens (human)
cellular response to hypoxiaVascular endothelial growth factor AHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIVascular endothelial growth factor AHomo sapiens (human)
angiogenesisVascular endothelial growth factor AHomo sapiens (human)
ovarian follicle developmentVascular endothelial growth factor AHomo sapiens (human)
branching involved in blood vessel morphogenesisVascular endothelial growth factor AHomo sapiens (human)
vasculogenesisVascular endothelial growth factor AHomo sapiens (human)
response to hypoxiaVascular endothelial growth factor AHomo sapiens (human)
in utero embryonic developmentVascular endothelial growth factor AHomo sapiens (human)
kidney developmentVascular endothelial growth factor AHomo sapiens (human)
positive regulation of protein phosphorylationVascular endothelial growth factor AHomo sapiens (human)
endothelial cell proliferationVascular endothelial growth factor AHomo sapiens (human)
positive regulation of endothelial cell proliferationVascular endothelial growth factor AHomo sapiens (human)
lymphangiogenesisVascular endothelial growth factor AHomo sapiens (human)
cell migration involved in sprouting angiogenesisVascular endothelial growth factor AHomo sapiens (human)
positive regulation of neuroblast proliferationVascular endothelial growth factor AHomo sapiens (human)
epithelial cell maturationVascular endothelial growth factor AHomo sapiens (human)
positive regulation of receptor internalizationVascular endothelial growth factor AHomo sapiens (human)
positive regulation of leukocyte migrationVascular endothelial growth factor AHomo sapiens (human)
heart morphogenesisVascular endothelial growth factor AHomo sapiens (human)
outflow tract morphogenesisVascular endothelial growth factor AHomo sapiens (human)
coronary vein morphogenesisVascular endothelial growth factor AHomo sapiens (human)
apoptotic processVascular endothelial growth factor AHomo sapiens (human)
nervous system developmentVascular endothelial growth factor AHomo sapiens (human)
neuroblast proliferationVascular endothelial growth factor AHomo sapiens (human)
mesoderm developmentVascular endothelial growth factor AHomo sapiens (human)
lactationVascular endothelial growth factor AHomo sapiens (human)
positive regulation of cell population proliferationVascular endothelial growth factor AHomo sapiens (human)
regulation of cell shapeVascular endothelial growth factor AHomo sapiens (human)
positive regulation of endothelial cell migrationVascular endothelial growth factor AHomo sapiens (human)
positive regulation of gene expressionVascular endothelial growth factor AHomo sapiens (human)
negative regulation of gene expressionVascular endothelial growth factor AHomo sapiens (human)
negative regulation of epithelial to mesenchymal transitionVascular endothelial growth factor AHomo sapiens (human)
monocyte differentiationVascular endothelial growth factor AHomo sapiens (human)
macrophage differentiationVascular endothelial growth factor AHomo sapiens (human)
lung developmentVascular endothelial growth factor AHomo sapiens (human)
positive regulation of cell migrationVascular endothelial growth factor AHomo sapiens (human)
epithelial cell differentiationVascular endothelial growth factor AHomo sapiens (human)
post-embryonic camera-type eye developmentVascular endothelial growth factor AHomo sapiens (human)
retinal ganglion cell axon guidanceVascular endothelial growth factor AHomo sapiens (human)
positive regulation of protein-containing complex assemblyVascular endothelial growth factor AHomo sapiens (human)
tube formationVascular endothelial growth factor AHomo sapiens (human)
endothelial cell chemotaxisVascular endothelial growth factor AHomo sapiens (human)
cellular response to vascular endothelial growth factor stimulusVascular endothelial growth factor AHomo sapiens (human)
lymph vessel morphogenesisVascular endothelial growth factor AHomo sapiens (human)
vascular endothelial growth factor receptor-2 signaling pathwayVascular endothelial growth factor AHomo sapiens (human)
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathwayVascular endothelial growth factor AHomo sapiens (human)
vascular endothelial growth factor signaling pathwayVascular endothelial growth factor AHomo sapiens (human)
positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathwayVascular endothelial growth factor AHomo sapiens (human)
VEGF-activated neuropilin signaling pathwayVascular endothelial growth factor AHomo sapiens (human)
vasodilationVascular endothelial growth factor AHomo sapiens (human)
eye photoreceptor cell developmentVascular endothelial growth factor AHomo sapiens (human)
negative regulation of apoptotic processVascular endothelial growth factor AHomo sapiens (human)
positive regulation of vascular permeabilityVascular endothelial growth factor AHomo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionVascular endothelial growth factor AHomo sapiens (human)
surfactant homeostasisVascular endothelial growth factor AHomo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic processVascular endothelial growth factor AHomo sapiens (human)
positive regulation of MAPK cascadeVascular endothelial growth factor AHomo sapiens (human)
positive regulation of blood vessel endothelial cell migrationVascular endothelial growth factor AHomo sapiens (human)
negative regulation of fat cell differentiationVascular endothelial growth factor AHomo sapiens (human)
positive regulation of osteoblast differentiationVascular endothelial growth factor AHomo sapiens (human)
positive regulation of angiogenesisVascular endothelial growth factor AHomo sapiens (human)
positive regulation of cell adhesionVascular endothelial growth factor AHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIVascular endothelial growth factor AHomo sapiens (human)
vascular endothelial growth factor receptor signaling pathwayVascular endothelial growth factor AHomo sapiens (human)
cell maturationVascular endothelial growth factor AHomo sapiens (human)
camera-type eye morphogenesisVascular endothelial growth factor AHomo sapiens (human)
positive regulation of axon extension involved in axon guidanceVascular endothelial growth factor AHomo sapiens (human)
artery morphogenesisVascular endothelial growth factor AHomo sapiens (human)
homeostasis of number of cells within a tissueVascular endothelial growth factor AHomo sapiens (human)
positive regulation of epithelial cell proliferationVascular endothelial growth factor AHomo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationVascular endothelial growth factor AHomo sapiens (human)
positive chemotaxisVascular endothelial growth factor AHomo sapiens (human)
positive regulation of positive chemotaxisVascular endothelial growth factor AHomo sapiens (human)
induction of positive chemotaxisVascular endothelial growth factor AHomo sapiens (human)
positive regulation of cell divisionVascular endothelial growth factor AHomo sapiens (human)
positive regulation of focal adhesion assemblyVascular endothelial growth factor AHomo sapiens (human)
cardiac muscle cell developmentVascular endothelial growth factor AHomo sapiens (human)
primitive erythrocyte differentiationVascular endothelial growth factor AHomo sapiens (human)
bone trabecula formationVascular endothelial growth factor AHomo sapiens (human)
lung vasculature developmentVascular endothelial growth factor AHomo sapiens (human)
mammary gland alveolus developmentVascular endothelial growth factor AHomo sapiens (human)
cardiac vascular smooth muscle cell developmentVascular endothelial growth factor AHomo sapiens (human)
coronary artery morphogenesisVascular endothelial growth factor AHomo sapiens (human)
vascular wound healingVascular endothelial growth factor AHomo sapiens (human)
cellular response to hypoxiaVascular endothelial growth factor AHomo sapiens (human)
dopaminergic neuron differentiationVascular endothelial growth factor AHomo sapiens (human)
commissural neuron axon guidanceVascular endothelial growth factor AHomo sapiens (human)
positive regulation of protein kinase C signalingVascular endothelial growth factor AHomo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisVascular endothelial growth factor AHomo sapiens (human)
positive regulation of branching involved in ureteric bud morphogenesisVascular endothelial growth factor AHomo sapiens (human)
motor neuron migrationVascular endothelial growth factor AHomo sapiens (human)
cellular stress response to acid chemicalVascular endothelial growth factor AHomo sapiens (human)
cell-cell adhesionVascular endothelial growth factor AHomo sapiens (human)
positive regulation of cold-induced thermogenesisVascular endothelial growth factor AHomo sapiens (human)
positive regulation of p38MAPK cascadeVascular endothelial growth factor AHomo sapiens (human)
positive regulation of vascular endothelial growth factor signaling pathwayVascular endothelial growth factor AHomo sapiens (human)
positive regulation of trophoblast cell migrationVascular endothelial growth factor AHomo sapiens (human)
positive regulation of lymphangiogenesisVascular endothelial growth factor AHomo sapiens (human)
regulation of hematopoietic progenitor cell differentiationVascular endothelial growth factor AHomo sapiens (human)
negative regulation of establishment of endothelial barrierVascular endothelial growth factor AHomo sapiens (human)
negative regulation of adherens junction organizationVascular endothelial growth factor AHomo sapiens (human)
positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesisVascular endothelial growth factor AHomo sapiens (human)
positive regulation of sprouting angiogenesisVascular endothelial growth factor AHomo sapiens (human)
negative regulation of blood-brain barrier permeabilityVascular endothelial growth factor AHomo sapiens (human)
negative regulation of cell-cell adhesion mediated by cadherinVascular endothelial growth factor AHomo sapiens (human)
positive regulation of endothelial cell chemotaxisVascular endothelial growth factor AHomo sapiens (human)
sprouting angiogenesisVascular endothelial growth factor AHomo sapiens (human)
positive regulation of mast cell chemotaxisVascular endothelial growth factor AHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (25)

Processvia Protein(s)Taxonomy
oxygen bindingAlbuminHomo sapiens (human)
DNA bindingAlbuminHomo sapiens (human)
fatty acid bindingAlbuminHomo sapiens (human)
copper ion bindingAlbuminHomo sapiens (human)
protein bindingAlbuminHomo sapiens (human)
toxic substance bindingAlbuminHomo sapiens (human)
antioxidant activityAlbuminHomo sapiens (human)
pyridoxal phosphate bindingAlbuminHomo sapiens (human)
identical protein bindingAlbuminHomo sapiens (human)
protein-folding chaperone bindingAlbuminHomo sapiens (human)
exogenous protein bindingAlbuminHomo sapiens (human)
enterobactin bindingAlbuminHomo sapiens (human)
fibronectin bindingVascular endothelial growth factor AHomo sapiens (human)
cytokine activityVascular endothelial growth factor AHomo sapiens (human)
platelet-derived growth factor receptor bindingVascular endothelial growth factor AHomo sapiens (human)
vascular endothelial growth factor receptor bindingVascular endothelial growth factor AHomo sapiens (human)
protein bindingVascular endothelial growth factor AHomo sapiens (human)
growth factor activityVascular endothelial growth factor AHomo sapiens (human)
heparin bindingVascular endothelial growth factor AHomo sapiens (human)
transmembrane receptor protein tyrosine kinase activator activityVascular endothelial growth factor AHomo sapiens (human)
chemoattractant activityVascular endothelial growth factor AHomo sapiens (human)
identical protein bindingVascular endothelial growth factor AHomo sapiens (human)
protein homodimerization activityVascular endothelial growth factor AHomo sapiens (human)
vascular endothelial growth factor receptor 1 bindingVascular endothelial growth factor AHomo sapiens (human)
vascular endothelial growth factor receptor 2 bindingVascular endothelial growth factor AHomo sapiens (human)
receptor ligand activityVascular endothelial growth factor AHomo sapiens (human)
extracellular matrix bindingVascular endothelial growth factor AHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (17)

Processvia Protein(s)Taxonomy
extracellular regionAlbuminHomo sapiens (human)
extracellular spaceAlbuminHomo sapiens (human)
nucleusAlbuminHomo sapiens (human)
endoplasmic reticulumAlbuminHomo sapiens (human)
endoplasmic reticulum lumenAlbuminHomo sapiens (human)
Golgi apparatusAlbuminHomo sapiens (human)
platelet alpha granule lumenAlbuminHomo sapiens (human)
extracellular exosomeAlbuminHomo sapiens (human)
blood microparticleAlbuminHomo sapiens (human)
protein-containing complexAlbuminHomo sapiens (human)
cytoplasmAlbuminHomo sapiens (human)
extracellular regionVascular endothelial growth factor AHomo sapiens (human)
extracellular spaceVascular endothelial growth factor AHomo sapiens (human)
nucleusVascular endothelial growth factor AHomo sapiens (human)
cytoplasmVascular endothelial growth factor AHomo sapiens (human)
endoplasmic reticulumVascular endothelial growth factor AHomo sapiens (human)
Golgi apparatusVascular endothelial growth factor AHomo sapiens (human)
adherens junctionVascular endothelial growth factor AHomo sapiens (human)
cell surfaceVascular endothelial growth factor AHomo sapiens (human)
membraneVascular endothelial growth factor AHomo sapiens (human)
secretory granuleVascular endothelial growth factor AHomo sapiens (human)
extracellular matrixVascular endothelial growth factor AHomo sapiens (human)
platelet alpha granule lumenVascular endothelial growth factor AHomo sapiens (human)
VEGF-A complexVascular endothelial growth factor AHomo sapiens (human)
extracellular spaceVascular endothelial growth factor AHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (24)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID208332Dissociation constant for matrix metalloprotease stromelysin2000Journal of medicinal chemistry, Sep-07, Volume: 43, Issue:18
Privileged molecules for protein binding identified from NMR-based screening.
AID1511992Agonist activity at Gal4-LBD fused RXRalpha (unknown origin) expressed in HEK293T cells at 30 uM after 14 to 16 hrs by dual-Glo luciferase assay2019ACS medicinal chemistry letters, Sep-12, Volume: 10, Issue:9
A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences.
AID210954Ability to bind TTR selectively over all other proteins in human blood plasma (equiv bound)2004Journal of medicinal chemistry, Jan-15, Volume: 47, Issue:2
Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis.
AID89369Transthyretin (TTR) amyloidogenesis inhibition activity by employing an acid-mediated (pH 4.4) WTTTR amyloid fibril formation assay, at 7.2 uM conc.2004Journal of medicinal chemistry, Jan-15, Volume: 47, Issue:2
Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis.
AID1467145Inhibition of mushroom tyrosinase using L-tyrosinase as substrate measured at 60 secs interval for 25 times2017Bioorganic & medicinal chemistry letters, 07-01, Volume: 27, Issue:13
Structural insight into the active site of mushroom tyrosinase using phenylbenzoic acid derivatives.
AID1628074Inhibition of mushroom tyrosinase monophenolase activity using L-tyrosine as substrate measured every 60 s for 25 times2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Discovery of a new type of scaffold for the creation of novel tyrosinase inhibitors.
AID1511993Agonist activity at Gal4-LBD fused RXRbeta (unknown origin) expressed in HEK293T cells at 30 uM after 14 to 16 hrs by dual-Glo luciferase assay2019ACS medicinal chemistry letters, Sep-12, Volume: 10, Issue:9
A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences.
AID243230Binding affinity towards human serum albumin2005Journal of medicinal chemistry, Apr-07, Volume: 48, Issue:7
Predicting human serum albumin affinity of interleukin-8 (CXCL8) inhibitors by 3D-QSPR approach.
AID89013Dissociation constant against DNA-binding domain of the human papillomavirus protein E22004Journal of medicinal chemistry, Jul-01, Volume: 47, Issue:14
Fragment-based drug discovery.
AID89368Transthyretin (TTR) amyloidogenesis inhibition activity by employing an acid-mediated (pH 4.4) WTTTR amyloid fibril formation assay, at 3.6 uM conc.2004Journal of medicinal chemistry, Jan-15, Volume: 47, Issue:2
Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis.
AID1628073Ratio of IC50 for mushroom tyrosinase diphenolase activity using L-DOPA as substrate to IC50 for mushroom tyrosinase monophenolase activity using L-tyrosine as substrate2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Discovery of a new type of scaffold for the creation of novel tyrosinase inhibitors.
AID1486518Inhibition of acid-induced wild type transthyretin (unknown origin) aggregation expressed in Escherichia coli pre-incubated for 30 mins before acid addition and further incubated for 72 hrs at 37 degC under dark conditions by UV-Vis spectrophotometry2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
AID1486519Binding affinity to transthyretin in human blood plasma assessed as plasma binding selectivity by measuring stoichiometry of small molecule bound to TTR incubated for 24 hrs at 37 degC by RP-HPLC2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
AID217168Dissociation constant against VEGF (vascular endothelial growth factor) was determined.2000Journal of medicinal chemistry, Sep-07, Volume: 43, Issue:18
Privileged molecules for protein binding identified from NMR-based screening.
AID1511994Agonist activity at Gal4-LBD fused RXRgamma (unknown origin) expressed in HEK293T cells at 30 uM after 14 to 16 hrs by dual-Glo luciferase assay2019ACS medicinal chemistry letters, Sep-12, Volume: 10, Issue:9
A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences.
AID1628075Inhibition of mushroom tyrosinase diphenolase activity using L-DOPA as substrate measured every 30 s for 25 times2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Discovery of a new type of scaffold for the creation of novel tyrosinase inhibitors.
AID65517Dissociation constant against E2-DBD (DNA binding domain) was determined.2000Journal of medicinal chemistry, Sep-07, Volume: 43, Issue:18
Privileged molecules for protein binding identified from NMR-based screening.
AID603953In-vivo plasma to lung partition coefficients of the compound, logP(lung) in rat2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
AID681123TP_TRANSPORTER: inhibition of lactate uptake in Xenopus laevis oocytes1999The Biochemical journal, Aug-01, Volume: 341 ( Pt 3)Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes.
AID681133TP_TRANSPORTER: inhibition of lactate uptake in Xenopus laevis oocytes1999The Biochemical journal, Aug-01, Volume: 341 ( Pt 3)Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes.
AID84392Dissociation constant after binding to human papillomavirus E2 DNA-binding domain (DBD) by observing the changes in [15N]-HSQC spectra.1997Journal of medicinal chemistry, Sep-26, Volume: 40, Issue:20
NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein.
AID84391Compound was tested for inhibition activity against HPV-E2 DNA-binding domain (DBD) (human papillomavirus E2) binding to DNA1997Journal of medicinal chemistry, Sep-26, Volume: 40, Issue:20
NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (22.58)18.7374
1990's9 (29.03)18.2507
2000's6 (19.35)29.6817
2010's8 (25.81)24.3611
2020's1 (3.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.85 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index4.60 (4.65)
Search Engine Demand Index36.91 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.23%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (96.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]